STAT | Reporting from the frontiers of health and medicine 中文 关注 STAT+:一家生物科技对冲基金催生了一家新免疫学公司” 一家生物科技公司为何决定从零开始建立一家新公司,以开发一种更优的长效抗体疗法用于治疗特应性皮炎。 STAT+: A biotech hedge fund births a new immunology company statnews.com STAT | Reporting from the frontiers of health and medicine 中文 RSS thenote.app